$316 Million is the total value of Prosight Management, LP's 41 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
INSP | New | INSPIRE MED SYS INC | $7,937,600 | – | 40,000 | +100.0% | 2.52% | – |
DXCM | New | DEXCOM INC | $5,823,879 | – | 62,421 | +100.0% | 1.85% | – |
UHS | New | UNIVERSAL HLTH SVCS INCcl b | $5,141,100 | – | 40,890 | +100.0% | 1.63% | – |
MASI | New | MASIMO CORP | $3,507,200 | – | 40,000 | +100.0% | 1.11% | – |
PEN | New | PENUMBRA INC | $3,265,785 | – | 13,500 | +100.0% | 1.04% | – |
DSGN | New | DESIGN THERAPEUTICS INC | $2,840,838 | – | 1,203,745 | +100.0% | 0.90% | – |
BBSI | New | BARRETT BUSINESS SVCS INC | $1,929,963 | – | 21,387 | +100.0% | 0.61% | – |
BMEA | New | BIOMEA FUSION INC | $1,304,682 | – | 94,817 | +100.0% | 0.41% | – |
CHE | New | CHEMED CORP NEW | $1,299,250 | – | 2,500 | +100.0% | 0.41% | – |
EOLS | New | EVOLUS INC | $1,160,615 | – | 126,982 | +100.0% | 0.37% | – |
New | ZYMEWORKS INC | $674,608 | – | 106,405 | +100.0% | 0.21% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ALDEYRA THERAPEUTICS INC | 19 | Q2 2023 | 6.2% |
ALBIREO PHARMA INC | 18 | Q4 2022 | 9.2% |
MEIRAGTX HOLDINGS PLC | 18 | Q3 2023 | 6.3% |
KEZAR LIFE SCIENCES INC | 17 | Q3 2023 | 8.2% |
ARENA PHARMACEUTICALS INC | 16 | Q4 2021 | 8.2% |
IOVANCE BIOTHERAPEUTICS INC | 16 | Q1 2022 | 7.7% |
CENTENE CORP DEL | 16 | Q3 2023 | 5.3% |
CUE BIOPHARMA INC | 14 | Q1 2023 | 5.6% |
PROTHENA CORP PLC | 13 | Q3 2023 | 13.6% |
ZIMMER BIOMET HOLDINGS INC | 13 | Q3 2021 | 9.8% |
View Prosight Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
EXICURE, INC. | February 14, 2022 | 2,426,508 | 2.2% |
Aldeyra Therapeutics, Inc. | February 12, 2021 | 908,488 | 2.3% |
Teligent, Inc. | February 14, 2020 | 1,484,527 | 2.8% |
Cidara Therapeutics, Inc. | February 14, 2019 | 245,764 | 0.9% |
Eiger BioPharmaceuticals, Inc.Sold out | February 14, 2019 | 0 | 0.0% |
Millendo Therapeutics, Inc. | February 14, 2019 | 256,739 | 2.0% |
OvaScience, Inc. | October 26, 2018 | 1,991,100 | 5.6% |
CHIMERIX INC | February 13, 2018 | 1,478,519 | 3.1% |
Harvard Apparatus Regenerative Technology, Inc. | February 12, 2016 | 184,360 | 1.4% |
View Prosight Management, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G | 2024-05-03 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G | 2024-01-02 |
13F-HR | 2023-11-14 |
View Prosight Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.